Proqr Therapeutics Bv Stock Price History
| PRQR Stock | USD 2.12 0.00 0.00% |
Below is the normalized historical share price chart for ProQR Therapeutics BV extending back to September 18, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ProQR Therapeutics stands at 2.12, as last reported on the 1st of February, with the highest price reaching 2.12 and the lowest price hitting 2.12 during the day.
If you're considering investing in ProQR Stock, it is important to understand the factors that can impact its price. ProQR Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.16, which implies the firm had a -0.16 % return per unit of risk over the last 3 months. ProQR Therapeutics exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ProQR Therapeutics' Risk Adjusted Performance of (0.09), variance of 24.49, and Coefficient Of Variation of (833.99) to confirm the risk estimate we provide.
At this time, ProQR Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 02/01/2025, Common Stock Shares Outstanding is likely to grow to about 97.8 M, while Liabilities And Stockholders Equity is likely to drop slightly above 108.5 M. . At this time, ProQR Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 02/01/2025, Price Earnings To Growth Ratio is likely to grow to 0.10, while Price Earnings Ratio is likely to drop (4.88). ProQR Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of September 2014 | 200 Day MA 2.3399 | 50 Day MA 2.9239 | Beta 0.253 |
ProQR |
Sharpe Ratio = -0.1572
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PRQR |
Estimated Market Risk
| 4.94 actual daily | 44 56% of assets are more volatile |
Expected Return
| -0.78 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ProQR Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ProQR Therapeutics by adding ProQR Therapeutics to a well-diversified portfolio.
Price Book 8.7395 | Enterprise Value Ebitda (2.10) | Price Sales 12.3844 | Shares Float 62.8 M | Wall Street Target Price 9.1667 |
ProQR Therapeutics Stock Price History Chart
There are several ways to analyze ProQR Stock price data. The simplest method is using a basic ProQR candlestick price chart, which shows ProQR Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 12, 2024 | 3.98 |
| Lowest Price | January 29, 2025 | 1.99 |
ProQR Therapeutics February 1, 2025 Stock Price Synopsis
Various analyses of ProQR Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ProQR Stock. It can be used to describe the percentage change in the price of ProQR Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ProQR Stock.| ProQR Therapeutics Price Rate Of Daily Change | 1.00 |
ProQR Therapeutics February 1, 2025 Stock Price Analysis
ProQR Stock Price History Data
The price series of ProQR Therapeutics for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 has a statistical range of 1.99 with a coefficient of variation of 20.05. The price distribution for the period has arithmetic mean of 3.08. The median price for the last 90 days is 3.31.| Open | High | Low | Close | Volume | ||
02/01/2025 | 2.12 | 2.12 | 2.12 | 2.12 | ||
| 01/31/2025 | 2.15 | 2.21 | 2.02 | 2.12 | 260,607 | |
| 01/30/2025 | 1.99 | 2.19 | 1.99 | 2.15 | 692,436 | |
| 01/29/2025 | 2.09 | 2.09 | 1.95 | 1.99 | 376,710 | |
| 01/28/2025 | 2.08 | 2.11 | 2.04 | 2.05 | 234,834 | |
| 01/27/2025 | 2.18 | 2.18 | 2.08 | 2.11 | 284,585 | |
| 01/24/2025 | 2.19 | 2.22 | 2.13 | 2.16 | 304,604 | |
| 01/23/2025 | 2.26 | 2.26 | 2.15 | 2.17 | 364,230 | |
| 01/22/2025 | 2.23 | 2.37 | 2.15 | 2.24 | 423,597 | |
| 01/21/2025 | 2.43 | 2.46 | 2.21 | 2.23 | 753,786 | |
| 01/17/2025 | 2.31 | 2.43 | 2.26 | 2.37 | 332,861 | |
| 01/16/2025 | 2.32 | 2.34 | 2.18 | 2.30 | 274,181 | |
| 01/15/2025 | 2.32 | 2.49 | 2.26 | 2.29 | 227,806 | |
| 01/14/2025 | 2.30 | 2.34 | 2.19 | 2.26 | 357,486 | |
| 01/13/2025 | 2.46 | 2.46 | 2.18 | 2.27 | 594,188 | |
| 01/10/2025 | 2.59 | 2.68 | 2.40 | 2.42 | 346,939 | |
| 01/08/2025 | 2.57 | 2.67 | 2.45 | 2.62 | 438,970 | |
| 01/07/2025 | 2.59 | 2.70 | 2.57 | 2.65 | 197,263 | |
| 01/06/2025 | 2.75 | 2.78 | 2.61 | 2.62 | 226,802 | |
| 01/03/2025 | 2.75 | 2.82 | 2.66 | 2.76 | 180,641 | |
| 01/02/2025 | 2.68 | 2.80 | 2.62 | 2.74 | 215,250 | |
| 12/31/2024 | 2.65 | 2.82 | 2.59 | 2.65 | 239,218 | |
| 12/30/2024 | 2.78 | 2.78 | 2.55 | 2.65 | 590,258 | |
| 12/27/2024 | 2.66 | 2.81 | 2.65 | 2.79 | 288,702 | |
| 12/26/2024 | 2.66 | 2.73 | 2.63 | 2.68 | 196,164 | |
| 12/24/2024 | 2.68 | 2.83 | 2.62 | 2.67 | 72,584 | |
| 12/23/2024 | 2.65 | 2.70 | 2.52 | 2.67 | 198,418 | |
| 12/20/2024 | 2.59 | 2.71 | 2.48 | 2.63 | 718,766 | |
| 12/19/2024 | 2.70 | 2.70 | 2.48 | 2.59 | 613,423 | |
| 12/18/2024 | 2.89 | 2.95 | 2.52 | 2.57 | 496,555 | |
| 12/17/2024 | 2.46 | 2.95 | 2.40 | 2.94 | 916,887 | |
| 12/16/2024 | 2.73 | 2.81 | 2.27 | 2.47 | 2,933,690 | |
| 12/13/2024 | 3.27 | 3.27 | 2.82 | 2.83 | 758,681 | |
| 12/12/2024 | 3.40 | 3.46 | 3.23 | 3.29 | 554,479 | |
| 12/11/2024 | 3.45 | 3.45 | 3.30 | 3.38 | 888,353 | |
| 12/10/2024 | 3.44 | 3.52 | 3.26 | 3.31 | 554,814 | |
| 12/09/2024 | 3.61 | 3.71 | 3.41 | 3.45 | 249,204 | |
| 12/06/2024 | 3.54 | 3.63 | 3.52 | 3.56 | 362,902 | |
| 12/05/2024 | 3.50 | 3.67 | 3.45 | 3.54 | 529,948 | |
| 12/04/2024 | 3.63 | 3.63 | 3.45 | 3.47 | 468,165 | |
| 12/03/2024 | 3.55 | 3.70 | 3.46 | 3.67 | 393,307 | |
| 12/02/2024 | 3.81 | 3.92 | 3.71 | 3.73 | 295,651 | |
| 11/29/2024 | 3.68 | 3.97 | 3.68 | 3.84 | 403,682 | |
| 11/27/2024 | 3.46 | 3.73 | 3.41 | 3.67 | 416,651 | |
| 11/26/2024 | 3.54 | 3.54 | 3.37 | 3.44 | 280,517 | |
| 11/25/2024 | 3.66 | 3.66 | 3.54 | 3.54 | 274,291 | |
| 11/22/2024 | 3.60 | 3.68 | 3.57 | 3.62 | 390,089 | |
| 11/21/2024 | 3.67 | 3.70 | 3.59 | 3.61 | 235,610 | |
| 11/20/2024 | 3.59 | 3.69 | 3.57 | 3.67 | 234,298 | |
| 11/19/2024 | 3.65 | 3.75 | 3.58 | 3.60 | 376,214 | |
| 11/18/2024 | 3.82 | 3.86 | 3.60 | 3.65 | 890,899 | |
| 11/15/2024 | 3.96 | 4.00 | 3.69 | 3.82 | 924,512 | |
| 11/14/2024 | 3.94 | 4.10 | 3.94 | 3.95 | 504,001 | |
| 11/13/2024 | 3.99 | 4.21 | 3.92 | 3.96 | 1,300,052 | |
| 11/12/2024 | 4.08 | 4.09 | 3.91 | 3.98 | 513,551 | |
| 11/11/2024 | 3.87 | 4.07 | 3.80 | 3.96 | 837,153 | |
| 11/08/2024 | 3.70 | 4.10 | 3.67 | 3.77 | 996,994 | |
| 11/07/2024 | 3.60 | 3.73 | 3.50 | 3.57 | 1,123,378 | |
| 11/06/2024 | 3.65 | 3.75 | 3.51 | 3.64 | 281,254 | |
| 11/05/2024 | 3.70 | 3.75 | 3.49 | 3.58 | 260,794 | |
| 11/04/2024 | 3.79 | 3.80 | 3.46 | 3.63 | 473,112 |
About ProQR Therapeutics Stock history
ProQR Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ProQR is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ProQR Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ProQR Therapeutics stock prices may prove useful in developing a viable investing in ProQR Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 93.2 M | 97.8 M | |
| Net Loss | -58.6 M | -61.5 M |
ProQR Therapeutics Quarterly Net Working Capital |
|
ProQR Therapeutics Stock Technical Analysis
ProQR Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
ProQR Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ProQR Therapeutics' price direction in advance. Along with the technical and fundamental analysis of ProQR Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ProQR to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (1.14) | |||
| Treynor Ratio | 0.6515 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for ProQR Stock Analysis
When running ProQR Therapeutics' price analysis, check to measure ProQR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProQR Therapeutics is operating at the current time. Most of ProQR Therapeutics' value examination focuses on studying past and present price action to predict the probability of ProQR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProQR Therapeutics' price. Additionally, you may evaluate how the addition of ProQR Therapeutics to your portfolios can decrease your overall portfolio volatility.